Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Duac Topical Gel (Clindamycin 1% and Benzoyl Peroxide 5%) to ACANY Gel (Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5%) Topical Acne Medications.

Trial Profile

Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Duac Topical Gel (Clindamycin 1% and Benzoyl Peroxide 5%) to ACANY Gel (Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5%) Topical Acne Medications.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Benzoyl peroxide/clindamycin (Primary)
  • Indications Acne vulgaris
  • Focus Adverse reactions
  • Sponsors Stiefel Laboratories
  • Most Recent Events

    • 10 Feb 2012 GlaxoSmithKline added as trial sponsor as reported by ClinicalTrials.gov.
    • 21 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top